MARIGO, ILARIA
MARIGO, ILARIA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
4PD functionalized dendrimers: A flexible tool for in vivo gene silencing of tumor-educated myeloid cells
2017 Zilio, S.; Vella, J. L.; De La Fuente, A. C.; Daftarian, P. M.; Weed, D. T.; Kaifer, A.; Marigo, I.; Leone, K.; Bronte, V.; Serafini, P.
Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma
2023 Dall’Olmo, Luigi; Papa, Nicole; Surdo, Nicoletta Concetta; Marigo, Ilaria; Mocellin, Simone
Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer
2024 Breusa, Silvia; Thomas, Eloise; Baldinotti, Noemi; Zilio, Serena; Delcros, Jean-Guy; Hernandez-Palomino, Diana Marcela; Qi, Weisha; Guérin, Hanäé; Gibert, Benjamin; Mehlen, Patrick; Marigo, Ilaria; Kryza, David; Lollo, Giovanna
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
2014 Bianchi, G.; Vuerich, M.; Pellegatti, P.; Marimpietri, D.; Emionite, L.; Marigo, I.; Bronte, V.; Di Virgilio, F.; Pistoia, V.; Raffaghello, L.
Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt delivery
2020 Matha, K.; Lollo, G.; Taurino, G.; Respaud, R.; Marigo, I.; Shariati, M.; Bussolati, O.; Vermeulen, A.; Remaut, K.; Benoit, J. -P.
Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery
2017 Trento, C.; Marigo, I.; Pievani, A.; Galleu, A.; Dolcetti, L.; Wang, C. -Y.; Serafini, M.; Bronte, V.; Dazzi, F.
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.
2005 Vincenzo, Bronte; Tihana, Kasic; Giorgia, Gri; Keti, Gallana; Giovanna, Borsellino; Marigo, Ilaria; Luca, Battistini; Iafrate, Massimo; TOMMASO PRAYER GALETTI, ; Francesco, Pagano; Viola, A.
Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells
2019 Ledo, A. M.; Sasso, M. S.; Bronte, V.; Marigo, I.; Boyd, B. J.; Garcia-Fuentes, M.; Alonso, M. J.
Complexity and challenges in defining myeloid-derived suppressor cells.
2015 Damuzzo, Vera; Pinton, Laura; Desantis, G; Solito, Samantha; Marigo, I; Bronte, V; Mandruzzato, Susanna
Derangement of immune responses by myeloid suppressor cells
2004 Serafini, P; DE SANTO, C; Marigo, I; Cingarlini, S; Dolcetti, L; Gallina, G; Zanovello, Paola; Bronte, V.
Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules
2019 Lollo, G.; Matha, K.; Bocchiardo, M.; Bejaud, J.; Marigo, I.; Virgone-Carlotta, A.; Dehoux, T.; Riviere, C.; Rieu, J. -P.; Briancon, S.; Perrier, T.; Meyer, O.; Benoit, J. -P.
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
2022 Chandra, J.; Hansen, M.; Labarriere, N.; Marigo, I.; Souza-Fonseca-Guimaraes, F.; Vujanovic, L.; Koguchi, Y.; Jacquelot, N.
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase.
2003 Bronte, V; Cingarlini, S; Apolloni, E; Serafini, P; Marigo, I; DE SANTO, C; Macino, Beatrice; Marin, Oriano; Zanovello, Paola
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma
2024 Ingangi, Vincenzo; De Chiara, Annarosaria; Ferrara, Gerardo; Gallo, Michele; Catapano, Antonio; Fazioli, Flavio; Di Carluccio, Gioconda; Peranzoni, Elisa; Marigo, Ilaria; Carriero, Maria Vincenza; Minopoli, Michele
GM-CSF and IL-6 induce tolerogenic myeloid-derived suppressor cells through C/EBP beta and allow long term islet allograft survival
2009 Bronte, V; Marigo, I; Bosio, E; Solito, Samantha; Mesa Pardillo, C; Fernandez, Ag; Dolcetti, L; Ugel, S; Sonda, N; Bicciato, S; Falisi, E; Besenzon, F; Calabrese, F; Zanovello, Paola; Basso, Giuseppe; Mandruzzato, Susanna; Cozzi, E.
GM-CSF Nitration Is a New Driver of Myeloid Suppressor Cell Activity in Tumors
2021 Cali, B.; Agnellini, A. H. R.; Cioccarelli, C.; Sanchez-Rodriguez, R.; Predonzani, A.; Toffolo, G. I.; Viola, A.; Bronte, V.; Arrigoni, G.; Zonta, F.; Albertoni, L.; Mescoli, C.; Marigo, I.; Molon, B.
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
2010 Dolcetti, L.; Peranzoni, E.; Ugel, S.; Marigo, I.; Gomez, A. F.; Mesa, C.; Geilich, M.; Winkels, G.; Traggiai, E.; Casati, A.; Grassi, F.; Bronte, V.
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice
2003 Bronte, V; Serafini, P; DE SANTO, C; Marigo, I; Tosello, V.; Mazzoni, A; Segal, Dm; Staib, C; Lowel, M; Sutter, G; Colombo, Mp; Zanovello, Paola
Improving the Therapeutic Potential of G-CSF through Compact Circular PEGylation Based on Orthogonal Conjugations
2023 Grigoletto, Antonella; Marotti, Valentina; Tedeschini, Tommaso; Campara, Benedetta; Marigo, Ilaria; Ingangi, Vincenzo; Pasut, Gianfranco
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer
2009 Ugel, S; Zoso, A; DE SANTO, C; Li, Y; Marigo, I.; Zanovello, Paola; Scarselli, E; Cipriani, B; Oelke, M; Schneck, Jp; Bronte, V.